![]() |
|||
![]() |
PUBMED Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, James, C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine JE, Calkins H. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2007 Jul 31;50(5):432-40. Epub 2007 Jul 16 Peters S. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres. J Cardiovasc Med (Hagerstown). 2007 Jul;8(7):521-6. Boriani G, Artale P, Biffi M, Martignani C, Frabetti L, Valzania C, Diemberger I, Ziacchi M, Bertini M, Rapezzi C, Parlapiano M, Branzi A. Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Vessels. 2007 May;22(3):184-92. Epub 2007 May 21. Yao Y, Zhang S, He DS, Zhang K, Hua W, Chu J, Pu J, Chen K, Wang F, Chen X. Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping. Pacing Clin Electrophysiol. 2007 Apr;30(4):526-33. Bakir I, Brugada P, Sarkozy A, Vandepitte C, Wellens F. A novel treatment strategy for therapy refractory ventricular arrhythmias in the setting of arrhythmogenic right ventricular dysplasia. Europace. 2007 May;9(5):267-9. Epub 2007 Mar 15. Pelliccia A, Corrado D, Bjornstad HH, Panhuyzen-Goedkoop N, Urhausen A, Carre F, Anastasakis A, Vanhees L, Arbustini E, Priori S. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil. 2006 Dec;13(6):876-885 Kies P, Bootsma M, Bax JJ, Zeppenfeld K, van Erven L, Wijffels MC, van der Wall EE, Schalij MJ. Serial reevaluation for ARVD/C is indicated in patients presenting with left bundle branch block ventricular tachycardia and minor ECG abnormalities. J Cardiovasc Electrophysiol. 2006 Jun;17(6):586-93. Peters S. Advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Int J Cardiol. 2006 Oct 26;113(1):4-11. Epub 2006 Jun 5. Satomi K, Kurita T, Suyama K, Noda T, Okamura H, Otomo K, Shimizu W, Aihara N, Kamakura S. Catheter ablation of stable and unstable ventricular tachycardias in patients with arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol. 2006 May;17(5):469-76. Kottkamp H, Hindricks G. Catheter ablation of ventricular tachycardia in ARVC: is curative treatment at the horizon? J Cardiovasc Electrophysiol. 2006 May;17(5):477-9. No abstract available. Bilchick KC, Judge DP, Calkins H, Marine JE. Use of a coronary sinus lead and biventricular ICD to correct a sensing abnormality in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol. 2006 Mar;17(3):317-20. Yoda M, Minami K, Fritzsche D, Tendrich G, Schulte-Eistrup S, Koerfer R. Three cases of orthotopic heart transplantation for arrhythmogenic right ventricular cardiomyopathy. Ann Thorac Surg. 2005 Dec;80(6):2358-60. Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli G, Calkins H. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2005 Nov;2(11):1188-94. Lemola K et al. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre. Heart. 2005 Sep;91(9):1167-72. Verma A et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation. 2005 Jun 21;111(24):3209-16. Epub 2005 Jun 13. Zou J et al. Dynamic substrate mapping and ablation of ventricular tachycardias in right ventricular dysplasia. J Interv Card Electrophysiol. 2004 Aug;11(1):37-45. Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2004 May 19;43(10):1843-52. Hebert JL, Chemla D, Gerard O, Zamani K, Quillard J, Azarine A, Frank R, Lecarpentier Y, Fontaine G. Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia. Am J Cardiol. 2004 Mar 15;93(6):728-33. Wichter T et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation. 2004 Mar 30;109(12):1503-8. Hosaka F et al. Amiodarone distribution in human tissues after long-term therapy: a case of arrhythmogenic right ventricular cardiomyopathy. Heart Vessels. 2002 May;16(4):154-6. |
||